Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report (Q77060987)
Jump to navigation
Jump to search
scientific article published on 01 November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report |
scientific article published on 01 November 2001 |
Statements
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report (English)
A Anthoney
W Fiedler
J P Droz
V Dieras
M Borner
J F Smyth
R Morant
M J de Vries
M Roelvink
P Fumoleau
European Organization for Research and Treatment of Cancer (EORTC)
1 November 2001